SCHEDULE 13G/A

Fennec Pharmaceuticals Inc

Common Shares · CUSIP: 31447P100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Rosalind Advisors, Inc.

  Shares: 2,746,840.00 · Class: 9.8%

• SALAMON STEVEN A J

  Shares: 2,680,174.00 · Class: 9.5%

• Aharon Gil

  Shares: 2,680,174.00 · Class: 9.5%

• Rosalind Master Fund L.P.

  Shares: 2,613,508.00 · Class: 9.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.